Page 1876 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1876
1668 Part X Transplantation
Vander Lugt MT, Braun TM, Hanash S, et al: ST2 as a marker for risk Zeiser R, Blazar BR: Preclinical models of acute and chronic graft-versus-host
of therapy-resistant graft-versus-host disease and death. N Engl J Med disease: how predictive are they for a successful clinical translation? Blood
369(6):529–539, 2013. 127:3117–3126, 2016.
Weiden PL, Flournoy N, Thomas ED, et al: Antileukemic effect of graft-
versus-host disease in human recipients of allogeneic-marrow grafts. N
Engl J Med 300:1068, 1979. REFERENCES
Wekerle T, Kurtz J, Ito H, et al: Allogeneic bone marrow transplantation with
co-stimulatory blockade induces macrochimerism and tolerance without For the complete list of references, log on to www.expertconsult.com.
cytoreductive host treatment. Nat Med 6:464, 2000.

